AbbVie (ABBV) Revenue — Quarter Ended Dec 31, 2025
Revenue for the quarter increased compared to the prior quarter and rose relative to the same quarter last year. The sequential and year-over-year gains reflect continued growth in the reported period.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 FY
Revenue for the quarter increased compared to the prior quarter and rose relative to the same quarter last year. The sequential and year-over-year gains reflect continued growth in the reported period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$16.6B
Revenue reported for this quarter.
Quarter-over-quarter
+5.3%
Change from the immediately preceding quarter.
Year-over-year
+10.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$61.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $13.3B | +8.4% |
| Jun 30, 2025 | $15.4B | +6.6% |
| Sep 30, 2025 | $15.8B | +9.1% |
| Dec 31, 2025 | $16.6B | +10.0% |
Revenue performance
The reported revenue moved higher, extending the upward trajectory seen throughout the fiscal year. Each quarter of the year showed a sequential increase, with the current quarter reaching the highest level.
Quarterly comparison
Compared with the immediately preceding quarter, revenue improved. Versus the same quarter one year earlier, revenue also increased, indicating a stronger performance in the current period.
What to watch
The filing context notes higher payments related to litigation matters and contingent consideration liabilities, which may affect future cash flows.